P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)
Keyword(s):
Keyword(s):
2007 ◽
Vol 5
(4)
◽
pp. 186-187
◽
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 6
(7)
◽
pp. 197
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):